KARA SCANLAN: Open Payments
NPI 1154409621 · GIG HARBOR, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 8 payments from 5 companies in 2025. Trend: 2023 $250 · 2024 $793 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 3 | $160 |
| Novo Nordisk Inc | 2 | $146 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Lilly USA, LLC | 1 | $123 |
Products named: PENMENVY, Ozempic, XIFAXAN, JARDIANCE, Wegovy.
Industry payments across WA — which companies pay providers there.
